Hypercholesterolemia Diagnosis

Hypercholesterolemia or raised blood cholesterol is a risk factor for cardiovascular events such as stroke or heart attack. Individuals with hypercholesterolemia are therefore advised to adopt lifestyle changes such as a healthy, balanced diet and regular exercise, to lower their risk of adverse health events.

A diagnosis of hypercholesterolemia is based on routine blood analysis to check levels of “bad” cholesterol, which includes triglycerides and low-density lipoproteins (LDLs). The blood is also checked for the presence of high-density lipoprotein (HDLs) or “good” cholesterol. The risk of cardiovascular disease is increased if the LDL or triglyceride level is raised or if the HDL level is lower than usual.

A patient is usually asked not to eat for at least 10 to 12 hours before the blood sample is taken, because undigested food can interfere with the outcome of the test.

The results of the blood tests are used to assess the patient’s risk of cardiovascular disease. Whether this risk is low, moderate or high is calculated based on the blood test results as well as other factors such as body mass index (BMI), age, gender, ethnicity and the presence of any modifiable risk factors such as high blood pressure or diabetes.

Governmental guidelines recommend that the total cholesterol level should be 5 mmol/L or less among healthy adults and 4 mmol/L or less among those at a high risk of cardiovascular disease. For LDL specifically, the blood level should be 3mmol/L or less in healthy adults and 2 mmol/L or less among those at high risk of cardiovascular disease. The HDL level should ideally be above 1 mmol/L.

Another measurement that is used to assess cardiovascular risk is the ratio of total cholesterol to HDL, which should be below 4.

The triglyceride level may also be assessed because an excess of these lipids can also increase the risk of cardiovascular problems. Ideally, the triglyceride level should be less than 1.7 mmol/L.

Further Reading

Last Updated: Jun 20, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 20). Hypercholesterolemia Diagnosis. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/health/Hypercholesterolemia-Diagnosis.aspx.

  • MLA

    Mandal, Ananya. "Hypercholesterolemia Diagnosis". News-Medical. 21 December 2024. <https://www.news-medical.net/health/Hypercholesterolemia-Diagnosis.aspx>.

  • Chicago

    Mandal, Ananya. "Hypercholesterolemia Diagnosis". News-Medical. https://www.news-medical.net/health/Hypercholesterolemia-Diagnosis.aspx. (accessed December 21, 2024).

  • Harvard

    Mandal, Ananya. 2023. Hypercholesterolemia Diagnosis. News-Medical, viewed 21 December 2024, https://www.news-medical.net/health/Hypercholesterolemia-Diagnosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U.S. cardiovascular disease costs set to skyrocket by 2050, new study reveals